|
May 13
|
One stock is dragging down the S&P 500's earnings growth
|
|
May 9
|
Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
|
|
May 9
|
Gilead's FOCUS Program Helps Zero In on Early HIV Detection
|
|
May 7
|
Gilead Helps Put African Nation on Path To Eliminate Hepatitis C
|
|
May 7
|
Gilead and Kite Oncology to Highlight Broad and Diverse Oncology Portfolio at ASCO 2024
|
|
Apr 27
|
Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Apr 26
|
FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV
|
|
Apr 25
|
Gilead Sciences Announces First Quarter 2024 Financial Results
|
|
Jan 16
|
Gilead Sciences with Emma's Story: Self-Advocacy in Breast Cancer
|
|
Jan 10
|
JPM's annual healthcare conference: Here's what's next for GLP-1s and the weight loss market
|
|
Jan 10
|
Gilead Pays Tribute to Patient Advocacy Work: Cara’s Story
|